TargetMol
Tigecycline is a broad-spectrum glycylcycline antibiotic derived from tetracycline. Tigecycline binds to the 30S ribosomal subunit, thereby interfering with the binding of aminoacyl-tRNA to the mRNA-ribosome complex.
More Information
Supplier Page
Olanzapine
50 mg
| Purity Not Available
TargetMol
Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
More Information
Supplier Page
Olanzapine
500 mg
| Purity Not Available
TargetMol
Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
More Information
Supplier Page
Olanzapine
100 mg
| Purity Not Available
TargetMol
Olanzapine is an atypical antipsychotic that is used currently in the treatment of schizophrenia and bipolar illness.
More Information
Supplier Page
TargetMol
Alarelin Acetate is a synthetic GnRH agonist which can directly inhibit proliferation and DNA synthesis of rat GSMC through GnRH receptors.
More Information
Supplier Page
TargetMol
Alarelin Acetate is a synthetic GnRH agonist which can directly inhibit proliferation and DNA synthesis of rat GSMC through GnRH receptors.
More Information
Supplier Page
Dutasteride
10 mg
| Purity Not Available
TargetMol
Dutasteride is a 5-alpha-reductase inhibitor that inhibits both type-1 and type2 isoforms of the enzyme and is used to treat benign prostatic hyperplasia.
More Information
Supplier Page
Dutasteride
50 mg
| Purity Not Available
TargetMol
Dutasteride is a 5-alpha-reductase inhibitor that inhibits both type-1 and type2 isoforms of the enzyme and is used to treat benign prostatic hyperplasia.
More Information
Supplier Page
TargetMol
Vildagliptin is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin’s cyano moiety undergoes hydrolysis and this inactive metabolite is excreted mainly via the urine.
More Information
Supplier Page
TargetMol